Inventor · disambiguated record
Subodh Deshmukh
Also filed as: DESHMUKH SUBODH · DESHMUKH SUBODH S · DESHMUKH SUBODH SHRINIVAS
9 granted patents·17 pending applications·7 citations·filing 2001–2017
79Inventor score
Top patents by PatentIndex Score
26 records- 0179US8372995B2Crystalline solid forms of tigecycline and methods of preparing sameWYETH LLC·Filed 2006·Granted Feb 12, 2013·4 cites·10 claims
- 0270US9469609B2Synthesis of pyrrolidine compoundsZEALAND PHARMA AS·Filed 2014·Granted Oct 18, 2016·1 cites·26 claims
- 0370US8927590B2Synthesis of pyrrolidine compoundsALIMARDANOV ASAF R·Filed 2012·Granted Jan 6, 2015·2 cites·3 claims
- 0455US2008188545A1Synthesis of pyrrolidine compoundsALIMARDANOV ASAF R·Filed 2007·Application pending·0 cites
- 0554US7595310B2Glucuronate salt of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Sep 29, 2009·0 cites·25 claims
- 0653US7615551B2Salicylate and gentisate salts of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Nov 10, 2009·0 cites·25 claims
- 0749US2008262008A1Crystalline forms and polymorphs of n-(3-(dimethylamino)propyl)-4-(4-(3-fluoro-4-methoxyphenyl) pyrimidin-2-ylamino) benzenesulfonamide as succinate saltsWYETH CORP·Filed 2008·Application pending·0 cites
- 0849US2010249207A1Synthesis of pyrrolidine compoundsWYETH LLC·Filed 2010·Application pending·0 cites
- 0949US2008275073A1Crystalline forms and polymorphs of n-(3-(dimethylamino)propyl)-4-(4-(3-fluoro-4-methoxyphenyl) pyrimidin-2-ylamino) benzenesulfonamide as pharmaceutically acceptable saltsWYETH CORP·Filed 2008·Application pending·0 cites
- 1048US7442707B2CCI-779 polymorph and use thereofWYETH CORP·Filed 2006·Granted Oct 28, 2008·0 cites·11 claims
- 1147US2007128731A1Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetryWYETH CORP·Filed 2006·Application pending·0 cites
- 1246US7435732B2Crystalline polymorphs of (3S)-N-hydroxy-4-({4-[-(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamideWYETH CORP·Filed 2005·Granted Oct 14, 2008·0 cites·27 claims
- 1345US2009093630A1Chiral synthesis of diazepinoquinolinesWYETH CORP·Filed 2008·Application pending·0 cites
- 1445US2008262010A1Crystalline polymorphs of n-(3-(dimethylamino)propyl)-4-(4-(3-fluoro-4-methoxyphenyl) pyrimidin-2-ylamino) benzenesulfonamide as d-glucoronate saltsWYETH CORP·Filed 2008·Application pending·0 cites
- 1545US2008262009A1Crystalline polymorphs of n-(3-(dimethylamino)propyl)-4-(4-(3-fluoro-4-methoxyphenyl) pyrimidin-2-ylamino) benzenesulfonamide as acetate saltsWYETH CORP·Filed 2008·Application pending·0 cites
- 1645US2008312306A1Polymorphs, solvates, and hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1h-pyrrole-2-carbonitrileWYETH CORP·Filed 2008·Application pending·0 cites
- 1744US7553843B2Process for the preparation of purified crystalline CCI-779WYETH CORP·Filed 2006·Granted Jun 30, 2009·0 cites·28 claims
- 1844US2008249148A1Synthesis and characterization of polymorph form III 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrileWYETH CORP·Filed 2008·Application pending·0 cites
- 1944US2009181953A1Compound forms and uses thereofWYETH CORP·Filed 2009·Application pending·0 cites
- 2044US2008234340A1Synthesis and characterization of polymorph form II of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-YL)thiazol-4-YL)benzonitrileWYETH CORP·Filed 2008·Application pending·0 cites
- 2140US2018318246A1Pharmaceutical compositions of dimethyl fumarateSUN PHARMACEUTICAL IND LTD·Filed 2016·Application pending·0 cites
- 2240US2006211699A1Quinoxaline dihydrohalide dihydrates and synthetic methods thereforWYETH CORP·Filed 2006·Application pending·0 cites
- 2339US2017340649A1Topical aqueous spray compositions of halobetasolSUN PHARMACEUTICAL IND LTD·Filed 2017·Application pending·0 cites
- 2439US2016346241A1Oral pharmaceutical composition of isotretinoinSUN PHARMACEUTICAL IND LTD·Filed 2015·Application pending·0 cites
- 2538US10022348B2Topical solution of isotretinoinSUN PHARMACEUTICAL IND LTD·Filed 2016·Granted Jul 17, 2018·0 cites·15 claims
- 2632US2002022659A1Crystalline and salt forms of an HIV protease inhibitorFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →